Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Pilot Study
Status: Enrolling
Updated:  12/31/1969
Metro Health System
mi
from
Cleveland, OH
Subcutaneous Furosemide in Acute Decompensated Heart Failure Pilot
Subcutaneous Furosemide in Acute Decompensated Heart Failure: The SUBQ-HF Pilot Study
Status: Enrolling
Updated: 12/31/1969
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects
GORE® Septal Occluder Clinical Study: A Study to Evaluate Safety and Efficacy in the Treatment of Transcatheter Closure of Ostium Secundum Atrial Septal Defects (ASDs)
Status: Enrolling
Updated:  12/31/1969
University of Virginia, Children's Hospital Heart Center
mi
from
Charlottesville, VA
Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects
GORE® Septal Occluder Clinical Study: A Study to Evaluate Safety and Efficacy in the Treatment of Transcatheter Closure of Ostium Secundum Atrial Septal Defects (ASDs)
Status: Enrolling
Updated: 12/31/1969
University of Virginia, Children's Hospital Heart Center
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Emory University School of Medicine
mi
from
Atlanta, GA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Brigham and Women's Hosp
mi
from
Boston, MA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Boston V.A. Healthcare System
mi
from
West Roxbury, MA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Boston V.A. Healthcare System
mi
from
West Roxbury, MA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
University of Missouri Health System
mi
from
Columbia, MO
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
University of Missouri Health System
mi
from
Columbia, MO
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
V.A St. Louis Health Care System
mi
from
Saint Louis, MO
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
V.A St. Louis Health Care System
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Stony Brook University Medical Center
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
University Hospitals of Cleveland Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Metro Health System
mi
from
Cleveland, OH
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Metro Health System
mi
from
Cleveland, OH
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Abington Memorial Hospital
mi
from
Abington, PA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
University of Pennsylvania Health System
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
Jefferson Medical College
mi
from
Philadelphia, PA
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
Jefferson Medical College
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated:  12/31/1969
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF
Status: Enrolling
Updated: 12/31/1969
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180 mg Compared to Placebo Added to Background Lipid-Modifying Therapy in Patients With Elevated LDL-C Who Are Statin Intolerant
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kenosha, WI
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
A Randomized, Double-Blind, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC-1002) 180 mg Compared to Placebo Added to Background Lipid-Modifying Therapy in Patients With Elevated LDL-C Who Are Statin Intolerant
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kenosha, WI
Click here to add this to my saved trials
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
A Long-term, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Not Adequately Controlled by Their Lipid-Modifying Therapy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
A Long-term, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Not Adequately Controlled by Their Lipid-Modifying Therapy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
A Long-term, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Not Adequately Controlled by Their Lipid-Modifying Therapy
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Georgetown, TX
Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
A Long-term, Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk Not Adequately Controlled by Their Lipid-Modifying Therapy
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Georgetown, TX
Click here to add this to my saved trials
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC 1002) 180 mg/Day as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Georgetown, TX
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study to Evaluate the Efficacy and Safety of Bempedoic Acid (ETC 1002) 180 mg/Day as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Georgetown, TX
Click here to add this to my saved trials
The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
The Estrogen Replacement and Atherosclerosis Trial
Status: Enrolling
Updated:  12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
The Estrogen Replacement and Atherosclerosis Trial
Status: Enrolling
Updated: 12/31/1969
Wake Forest University School of Medicine
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Capnography in the Post-Anesthesia Care Unit (PACU)
Preliminary Characterization of the Capnography Profile of Obstructive Sleep Apnea (OSA) Patients in the Post-Anesthesia Care Unit (PACU)
Status: Enrolling
Updated:  12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Capnography in the Post-Anesthesia Care Unit (PACU)
Preliminary Characterization of the Capnography Profile of Obstructive Sleep Apnea (OSA) Patients in the Post-Anesthesia Care Unit (PACU)
Status: Enrolling
Updated: 12/31/1969
Tampa General Hospital
mi
from
Tampa, FL
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Abrazo Arizona Heart Hospital
mi
from
Phoenix, AZ
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Abrazo Arizona Heart Hospital
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
VA San Diego
mi
from
San diego, CA
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
VA San Diego
mi
from
San diego, CA
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Northwestern University
mi
from
Chicago, IL
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
New Mexico Heart Institute
mi
from
Albuquerque, NM
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
New Mexico Heart Institute
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Mission Hospital, Inc
mi
from
Asheville, NC
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Mission Hospital, Inc
mi
from
Asheville, NC
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
North Central Heart
mi
from
Sioux Falls, SD
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
North Central Heart
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Wellmont CVA Heart Institute
mi
from
Kingsport, TN
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Wellmont CVA Heart Institute
mi
from
Kingsport, TN
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Baylor St. Luke's Medical Center
mi
from
Houston, TX
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Baylor St. Luke's Medical Center
mi
from
Houston, TX
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Swedish Heart and Vascular Research
mi
from
Seattle, WA
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Swedish Heart and Vascular Research
mi
from
Seattle, WA
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
Carle Foundation Hospital
mi
from
Urbana, IL
Click here to add this to my saved trials
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated:  12/31/1969
University at Buffalo Clinical Translational Research Center/Kaleida Health/GVI/Buffalo General Medical Center
mi
from
Buffalo, NY
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE (Investigational Device Exemption) Study
Expanding Patient Applicability With Polymer Sealing Ovation Alto Stent Graft IDE Study
Status: Enrolling
Updated: 12/31/1969
University at Buffalo Clinical Translational Research Center/Kaleida Health/GVI/Buffalo General Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Chan Heart Rhythm Institute
mi
from
Mesa, AZ
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Chan Heart Rhythm Institute
mi
from
Mesa, AZ
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Dallas VA Hospital
mi
from
Dallas, TX
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Dallas VA Hospital
mi
from
Dallas, TX
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Cardiovascular Consultants, Ltd.
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
University Hospital gGmbH Bergmannsheil
mi
from
Bochum,
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
University Hospital gGmbH Bergmannsheil
mi
from
Bochum,
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Arizona Arrhythmia Consultants
mi
from
Scottsdale, AZ
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Arizona Arrhythmia Consultants
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Southwest Cardiology Associates
mi
from
Mesa, AZ
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Southwest Cardiology Associates
mi
from
Mesa, AZ
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Pima Heart Physicians
mi
from
Tucson, AZ
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Pima Heart Physicians
mi
from
Tucson, AZ
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Baptist Health Systems
mi
from
Lexington, IL
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Baptist Health Systems
mi
from
Lexington, IL
Click here to add this to my saved trials
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated:  12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System
FIX-HF-5C2: Evaluation of the Safety and Efficacy of the 2-lead OPTIMIZER® Smart System in Subjects With Moderate-to-Severe Heart Failure With Ejection Fraction Between 25% and 45%
Status: Enrolling
Updated: 12/31/1969
Ochsner Clinic Foundation
mi
from
New Orleans, LA
Click here to add this to my saved trials